Pages that link to "Q34367696"

The following pages link to NMDA receptor pharmacology: perspectives from molecular biology (Q34367696):

Displaying 43 items.

• The N-methyl-D-aspartate receptor modulator GLYX-13 enhances learning and memory, in young adult and learning impaired aging rats (Q24629141) (← links)
• Cellular interplay between neurons and glia: toward a comprehensive mechanism for excitotoxic neuronal loss in neurodegeneration (Q24654460) (← links)
• Beyond the dopamine receptor: novel therapeutic targets for treating schizophrenia (Q30473410) (← links)
• N-methyl-d-aspartate (NMDA) receptor dysfunction or dysregulation: the final common pathway on the road to schizophrenia? (Q30474021) (← links)
• Differential role of N-methyl-D-aspartate receptor subunits 2A and 2B in mediating phencyclidine-induced perinatal neuronal apoptosis and behavioral deficits (Q30478715) (← links)
• Therapeutic potential of positive AMPA modulators and their relationship to AMPA receptor subunits. A review of preclinical data (Q30981408) (← links)
• Selective Vulnerabilities of N-methyl-D-aspartate (NMDA) Receptors During Brain Aging. (Q33868364) (← links)
• Glutamate and schizophrenia: beyond the dopamine hypothesis (Q33996803) (← links)
• HIV-associated neurocognitive disorder: pathogenesis and therapeutic opportunities (Q34037622) (← links)
• Human olfactory epithelial cells generated in vitro express diverse neuronal characteristics (Q34180994) (← links)
• Neuroplasticity signaling pathways linked to the pathophysiology of schizophrenia (Q34423863) (← links)
• Development of NMDA NR2 subunits and their roles in critical period maturation of neocortical GABAergic interneurons (Q35013120) (← links)
• FOXO/TXNIP pathway is involved in the suppression of hepatocellular carcinoma growth by glutamate antagonist MK-801. (Q35013518) (← links)
• Switching of N-Methyl-d-aspartate (NMDA) Receptor-favorite Intracellular Signal Pathways from ERK1/2 Protein to p38 Mitogen-activated Protein Kinase Leads to Developmental Changes in NMDA Neurotoxicity (Q35063463) (← links)
• Glutamate receptor composition of the post-synaptic density is altered in genetic mouse models of NMDA receptor hypo- and hyperfunction (Q35575573) (← links)
• Isoflurane/nitrous oxide anesthesia induces increases in NMDA receptor subunit NR2B protein expression in the aged rat brain (Q35635655) (← links)
• N-methyl-D-aspartate receptor mechanosensitivity is governed by C terminus of NR2B subunit (Q35763200) (← links)
• Discovery of 3-substituted aminocyclopentanes as potent and orally bioavailable NR2B subtype-selective NMDA antagonists (Q36015381) (← links)
• Bacopa monnieri Extract (CDRI-08) Modulates the NMDA Receptor Subunits and nNOS-Apoptosis Axis in Cerebellum of Hepatic Encephalopathy Rats (Q36043633) (← links)
• Glutamate dysfunction in hippocampus: relevance of dentate gyrus and CA3 signaling (Q36245030) (← links)
• Targeting prefrontal cortical dopamine D1 and N-methyl-D-aspartate receptor interactions in schizophrenia treatment (Q36252816) (← links)
• Calpain and synaptic function (Q36586276) (← links)
• Fyn-mediated phosphorylation of NR2B Tyr-1336 controls calpain-mediated NR2B cleavage in neurons and heterologous systems (Q36766030) (← links)
• Looking for novel ways to treat the hallmarks of Alzheimer's disease (Q36904846) (← links)
• Cocaine Self-Administration Elevates GluN2B within dmPFC Mediating Heightened Cue-Elicited Operant Responding (Q37130682) (← links)
• The potential of targeting NMDA receptors outside the CNS. (Q38286249) (← links)
• Subtype-selective antagonism of N-methyl-D-aspartate receptor ion channels by synthetic conantokin peptides (Q38496804) (← links)
• Gene expression of glutamate receptors GluR1 and NR1 is differentially modulated in striatal neurons in rats after 6-hydroxydopamine lesion (Q39656483) (← links)
• N-methyl-D-aspartate receptor-dependent regulation of the glutamate transporter excitatory amino acid carrier 1. (Q42511740) (← links)
• CXCL12 inhibits expression of the NMDA receptor's NR2B subunit through a histone deacetylase-dependent pathway contributing to neuronal survival (Q42587773) (← links)
• Functional Glutamate Signaling in Bone (Q42914511) (← links)
• Exploring the role of amino acid-18 of the leucine binding proteins of E. coli (Q44220149) (← links)
• Effects of intraocular injection of a low concentration of zinc on the rat retina (Q44563673) (← links)
• (19)F NMR studies of the leucine-isoleucine-valine binding protein: evidence that a closed conformation exists in solution (Q44574022) (← links)
• Insight into the stability of the hydrophobic binding proteins ofescherichia coli:Assessing the proteins for use as biosensors (Q44601566) (← links)
• Interactions of postsynaptic density-95 and the NMDA receptor 2 subunit control calpain-mediated cleavage of the NMDA receptor. (Q45182523) (← links)
• Human immunodeficiency virus (HIV)-induced neurotoxicity: roles for the NMDA receptor subtypes. (Q45420727) (← links)
• Diverse and often opposite behavioural effects of NMDA receptor antagonists in rats: implications for "NMDA antagonist modelling" of schizophrenia. (Q46022286) (← links)
• Structural characterization of the intermolecular interactions of synapse-associated protein-97 with the NR2B subunit of N-methyl-D-aspartate receptors (Q46522305) (← links)
• N-methyl-D-aspartate receptor subtype mediated bidirectional control of p38 mitogen-activated protein kinase (Q46557740) (← links)
• Chronic stress modulation of prefrontal cortical NMDA receptor expression disrupts limbic structure-prefrontal cortex interaction (Q49144480) (← links)
• Potentiation of mouse vagal afferent mechanosensitivity by ionotropic and metabotropic glutamate receptors (Q60730313) (← links)
• The differential contribution of GluN1 and GluN2 to the gating operation of the NMDA receptor channel (Q85844030) (← links)